It takes a lot to surprise me these days in the cell therapy and regenerative medicine space, but some news from Walgreens stopped me in my tracks yesterday. The firm most well known for its drug stores and pharmacies has been struggling recently. Perhaps as a way to try to turn things around, they recently […]
New Walgreens shopping list: q-tips, aspirin, & cutting-edge gene & cell therapies Read More »
Let’s start with some stem cell good news on evolving approaches to treat sickle cell disease involving stem cells. Then on another related front things were more concerning. Stem cell good news on sickle cell disease, a complication Sickle Cell Disease News reports Adding Briquilimab Boosts Success of Sickle Cell Stem Cell Transplant. This is a
Weekly reads: stem cell good news, bad news on sickle cell, MS, IPSCs Read More »
How promising is the idea of stem cells for MS? I have been working slowly as time permits on a piece more specifically about hematopoietic stem cell transplantation (HSCT) for MS. Two new pieces caught my eye on this topic so I’ll start with those. Stem cells for MS NurOwn Found Safe, Shows Promise in
Weekly reads: stem cells for MS, blood origins, iPSCs Read More »
What happens following pluripotent stem cell transplants into the brain? Are human IPS and ES cells going to function similarly in this context? We recently published a new translational paper on the behavior of human pluripotent stem cells when transplanted into the adult mouse brain in collaboration with my great UC Davis colleague, Dr. Veronica Martinez-Cerdeno.
I’m working on an investigative story on fake news in the stem cell and regenerative medicine arena. Is there a growing stem cell fake news problem in the biotech world? More broadly, the SEC is cracking down on the mess that is fake biotech news, but what about publicly-traded stem cell biotechs more specifically? Already in the past
Ongoing story on stem cell fake news: send me your tips Read More »
It’s a particularly exciting time for the stem cell field. One of the most notable developments in the last year or so is the production and preliminary study of a totally new type of human embryonic stem cells (ESC) made by nuclear transfer instead of using leftover in vitro fertilization (IVF) embryos. This process of so-called
Dieter Egli Interview: NT-ES cells, IPSC, Mitochondrial Transfer, & More Read More »
Hi everyone, I’m in the process of migrating this blog to a new host server called wpengine. As a result, during this process it is possible that the website may look funny, be missing certain elements, or be down over the next few days. Thanks for your patience. Paul
Heads up to readers: www.ipscell.com host migration Read More »
The iPS cell field has had a relatively quiet 2012 so far, but one recent paper has drawn particular attention in the last 10 days. I’m talking about the paper from Jaenisch’s lab on iPS cells in Cell. Quite a few people are excited, but also scratching their heads a bit as to what this
Jaenisch’s new, complicated iPS paper in Cell: what the heck does it all mean? Read More »
Many folks believe that if you can kill or otherwise inactivate cancer stem cells, you’ve gone a long way to curing many types of cancer. However the cells have remained elusive. Now, Mick Bhatia’s lab has found that the antipsychotic drug, Thioridazine, has activity against cancer stem cells. The work, published in Cell (read paper
Cord blood banker Cryo-Cell and Duke have had a long-running agreement. The potentially multi-million dollar deal has focused on the development of possible umbilical cord blood therapies for pediatric patients. A major first goal has been to open an infusion clinic, which I have been very skeptical about for various reasons. For instance, one big
Cryo-Cell alleges Duke acted “fraudulently” related to pediatric cord cell deal Read More »